Article info
PDFReview
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
- Correspondence to Dr Marcia A Friedman, Medicine, Oregon Health & Science University, Portland, OR 97239, USA; friedmam{at}ohsu.edu
Citation
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
Publication history
- Received July 27, 2021
- Accepted August 25, 2021
- First published September 7, 2021.
Online issue publication
September 13, 2021
Article Versions
- Previous version (7 September 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.